Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients With Liver Cirrhosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02468479
Recruitment Status : Completed
First Posted : June 10, 2015
Last Update Posted : April 19, 2017
Sponsor:
Information provided by (Responsible Party):
Xingshun Qi, General Hospital of Shenyang Military Region

Brief Summary:
Chest/abdominal wall varices and spider nevi are two common presenting signs of liver cirrhosis. Their prognostic values remain unclear.

Condition or disease Intervention/treatment
Liver Cirrhosis Other: No relevant intervention.

Layout table for study information
Study Type : Observational
Actual Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prognostic Values of Chest/Abdominal Wall Varices and Spider Nevi in Patients
Study Start Date : June 2015
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 2016

Resource links provided by the National Library of Medicine



Intervention Details:
  • Other: No relevant intervention.
    No relevant intervention.


Primary Outcome Measures :
  1. Prevalence and type of chest/abdominal wall varices and spider nevi [ Time Frame: 1.5 years ]
    Baseline data

  2. Association between etiology of liver cirrhosis and type of chest/abdominal wall varices and spider nevi [ Time Frame: 1.5 years ]
    Baseline data

  3. Association between degree of liver function and type of chest/abdominal wall varices and spider nevi [ Time Frame: 1.5 years ]
    Baseline data

  4. Effect of chest/abdominal wall varices and spider nevi on survival [ Time Frame: 2.5 years or more ]
    Follow-up data



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with a diagnosis of liver cirrhosis who are consecutively admitted to our department.
Criteria

Inclusion Criteria:

  1. Liver cirrhosis.
  2. Consecutive admission.
  3. Permitted to physical examinations.
  4. Informed consents.

Exclusion Criteria:

  1. Non-cirrhotic portal hypertension.
  2. Malignancy.
  3. Uncontrolled infection.
  4. Severe chronic diseases.
  5. Poor patient compliance.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02468479


Locations
Layout table for location information
China, Liaoning
Department of Gastroenterology, General Hospital of Shenyang Military Area
Shenyang, Liaoning, China, 110840
Sponsors and Collaborators
General Hospital of Shenyang Military Region
Investigators
Layout table for investigator information
Principal Investigator: Xiaozhong Guo, MD, PhD Department of Gastroenterology, General Hospital of Shenyang Military Area
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Xingshun Qi, Doctor, General Hospital of Shenyang Military Region
ClinicalTrials.gov Identifier: NCT02468479    
Other Study ID Numbers: CAWV-LC
First Posted: June 10, 2015    Key Record Dates
Last Update Posted: April 19, 2017
Last Verified: April 2017
Keywords provided by Xingshun Qi, General Hospital of Shenyang Military Region:
Liver cirrhosis
Additional relevant MeSH terms:
Layout table for MeSH terms
Liver Cirrhosis
Fibrosis
Pathologic Processes
Liver Diseases
Digestive System Diseases